AEROVATE IMPAHCT FUL AV-101-003 IMPAHCT-FUL: A Long-Term Extension, Multi-Center Safety Study of AV-101 in Subjects With Pulmonary Arterial Hypertension (PAH) Who Have Completed Study AV-101-002
Clinical Trial Grant
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
Aerovate Therapeutics, Inc
Start Date
April 20, 2023
End Date
November 5, 2024
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
Aerovate Therapeutics, Inc
Start Date
April 20, 2023
End Date
November 5, 2024